today announced that updated clinical data from a fully enrolled Stage 1 trial of its investigational, pan-BCR-ABL inhibitor, ponatinib, will be offered at the 52nd Annual Meeting of the American Culture of Hematology being held in Orlando, Florida, 4-7 December, 2010. These Phase 1 findings in individuals with resistant and refractory chronic myeloid leukemia will be featured in an oral presentation and can also be highlighted in a webcast investor meeting being held at ASH. The schedule and places for the investor meeting and oral display session are listed below:..A written report by the San Rafael, Calif.-centered Marin Institute, which describes itself as an alcohol industry watchdog group, stated 500 fresh energy drink products were introduced worldwide last year. Michele Simon, research and plan director of the combined group, said about 20 brands are alcoholic beverages and have come on the marketplace within the last 10 years. Furthermore to Oregon and Connecticut, states mixed up in actions are Alaska, Arizona, California, Idaho, Illinois, Iowa, Kansas, Kentucky, Louisiana, Maine, Maryland, Michigan, Mississippi, Nevada, New Mexico, New York, Ohio, Oklahoma, Rhode Island, SC, Tennessee, Utah, Vermont, Washington, West Virginia and Wyoming.
Abortion prices highest where it’s illegal: Study Abortion prices are highest where the procedure is illegal, according to a fresh study.